|
1
|
McGrath JA, Schofield OM and Eady RA:
Epidermolysis bullosa pruriginosa: Dystrophic epidermolysis bullosa
with distinctive clinicopathological features. Br J Dermatol.
130:617–625. 1994.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bardhan A, Bruckner-Tuderman L, Chapple
ILC, Fine JD, Harper N, Has C, Magin TM, Marinkovich MP, Marshall
JF, McGrath JA, et al: Epidermolysis bullosa. Nat Rev Dis Primers.
6(78)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Dang N and Murrell DF: Mutation analysis
and characterization of COL7A1 mutations in dystrophic
epidermolysis bullosa. Exp Dermatol. 17:553–568. 2008.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bremer J, van der Heijden EH, Eichhorn DS,
Meijer R, Lemmink HH, Scheffer H, Sinke RJ, Jonkman MF, Pasmooij
AMG and Van*den*Akker PC: Natural exon skipping sets the stage for
exon skipping as therapy for dystrophic epidermolysis Bullosa. Mol
Ther Nucleic Acids. 18:465–475. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Pulkkinen L and Uitto J: Mutation analysis
and molecular genetics of epidermolysis bullosa. Matrix Biol.
18:29–42. 1999.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kim WB, Alavi A, Walsh S, Kim S and Pope
E: Epidermolysis bullosa pruriginosa: A systematic review exploring
genotype-phenotype correlation. Am J Clin Dermatol. 16:81–87.
2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Fine JD: Inherited epidermolysis bullosa.
Orphanet J Rare Dis. 5(12)2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Uitto J, McGrath JA, Rodeck U,
Bruckner-Tuderman L and Clare*Robinson E: Progress in epidermolysis
bullosa research: Toward treatment and cure. J Invest Dermatol.
130:1778–1784. 2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Takeichi T, Liu L, Fong K, Ozoemena L,
McMillan JR, Salam A, Campbell P, Akiyama M, Mellerio JE, McLean
WH, et al: Whole-exome sequencing improves mutation detection in a
diagnostic epidermolysis bullosa laboratory. Br J Dermatol.
172:94–100. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Fozia F, Nazli R, Alrashed MM, Ghneim HK,
Haq ZU, Jabeen M, Alam Khan S, Ahmad I, Bourhia M and Aboul-Soud
MAM: Detection of novel biallelic causative variants in COL7A1 gene
by whole-exome sequencing, resulting in congenital recessive
dystrophic epidermolysis bullosa in three unrelated families.
Diagnostics (Basel). 12(1525)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Fozia F, Nazli R, Bibi N, Khan SA,
Muhammad N, Shakeeb N, Khan S, Jelani M and Wasif N: Whole exome
sequencing confirms molecular diagnostics of three pakhtun families
with autosomal recessive epidermolysis Bullosa. Front Pediatr.
9(727288)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Albertsen HM, Matalliotaki C,
Matalliotakis M, Zervou MI, Matalliotakis I, Spandidos DA, Chettier
R, Ward K and Goulielmos GN: Whole exome sequencing identifies
hemizygous deletions in the UGT2B28 and USP17L2 genes in a
three-generation family with endometriosis. Mol Med Rep.
19:1716–1720. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hashmi JA, Safar RA, Afzal S, Albalawi AM,
Abdu-Samad F, Iqbal Z and Basit S: Whole exome sequencing
identification of a novel insertion mutation in the phospholipase C
ε-1 gene in a family with steroid resistant inherited nephrotic
syndrome. Mol Med Rep. 18:5095–5100. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Mandel P and Metais P: Nuclear acids in
human blood plasma. C R Seances Soc Biol Fil. 142:241–243.
1948.PubMed/NCBI(In French).
|
|
15
|
de Miranda FS, Barauna VG, dos Santos L,
Costa G, Vassallo PF and Campos LCG: Properties and application of
cell-free DNA as a clinical biomarker. Int J Mol Sci.
22(9110)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Han DSC and Lo YMD: The nexus of cfDNA and
nuclease biology. Trends Genet. 37:758–770. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li X, Qian H, Sogame R, Hirako Y, Tsuruta
D, Ishii N, Koga H, Tsuchisaka A, Jin Z, Tsubota K, et al: Integrin
β4 is a major target antigen in pure ocular mucous membrane
pemphigoid. Eur J Dermatol. 26:247–253. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Liu W, Sun X, Gao Y, Li H, Shi L, Cheng L,
Zhou Z, Li X and Qian H: A Chinese case of concurrent anti-laminin
γ1 pemphigoid and anti-laminin 332-type mucous membrane pemphigoid.
J Dermatol. 50:e69–e71. 2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Dainichi T, Kurono S, Ohyama B, Ishii N,
Sanzen N, Hayashi M, Shimono C, Taniguchi Y, Koga H, Karashima T,
et al: Anti-laminin gamma-1 pemphigoid. Proc Natl Acad Sci USA.
106:2800–2805. 2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Christiano AM, Hoffman GG, Zhang X, Xu Y,
Tamai Y, Greenspan DS and Uitto J: Strategy for identification of
sequence variants in COL7A1 and a novel 2-bp deletion mutation in
recessive dystrophic epidermolysis bullosa. Hum Mutat. 10:408–414.
1997.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yang J, Yan R, Roy A, Xu D, Poisson J and
Zhang Y: The I-TASSER Suite: Protein structure and function
prediction. Nat Methods. 12:7–8. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chai ZT, Lim YL, Busmanis I and Pang SM:
Anti-laminin-γ1 pemphigoid in an epitope spreading phenomenon,
successfully treated with rituximab. Int J Dermatol. 61:508–510.
2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li S, Xiang R, Jing K, Li Z, Wang Y, Zhang
H, Li X and Feng S: Diagnostic values of indirect
immunofluorescence using salt-split skin, direct immunofluorescence
and BP180 NC16A ELISA on bullous pemphigoid. Chin Med J (Engl).
135:1379–1380. 2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Li X, Tsuchisaka A, Qian H, Teye K, Ishii
N, Sogame R, Harada K, Nakagomi D, Shimada S, Tateishi C, et al:
Linear IgA/IgG bullous dermatosis reacts with multiple laminins and
integrins. Eur J Dermatol. 25:418–423. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhou Y, Zhou X, Feng X, Xia D, Qian H, Liu
H, Li X and Li W: Case Report: Prurigo nodularis-like linear
IgA/IgG bullous dermatosis: A case report and literature review.
Front Immunol. 14(1201163)2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Shi L, Li X and Qian H: Anti-Laminin
332-type mucous membrane pemphigoid. Biomolecules.
12(1461)2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Liu W, Li H, Jin Y, Cheng L, Shi L, Gao Y,
Zhou Z, Feng S, Qian H, Hashimoto T and Li X: Case report: Mucous
membrane pemphigoid with complicated autoantibody profile
indicating the necessity of comprehensive diagnostic methods and
the contribution of IgA autoantibodies. Front Immunol.
14(1149119)2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yajima M, Kitoh A, Nakano H, Sawamura D,
Miyachi Y and Kabashima K: Dominant dystrophic epidermolysis
bullosa pruriginosa with the G2287R mutation. Eur J Dermatol.
22:685–687. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hayashi M, Kawaguchi M, Hozumi Y, Nakano
H, Sawamura D and Suzuki T: Dystrophic epidermolysis bullosa
pruriginosa of elderly onset. J Dermatol. 38:173–178.
2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chao YC, Hong JB, Liu C, Lee MS and Lin
RY: COL7A1 G2287R mutation with two clinical phenotypes in the same
family: Bullous dermolysis of the newborn and dystrophic
epidermolysis bullosa pruriginosa. J Dermatol. 49:e313–e314.
2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Alcaide M, Cheung M, Hillman J, Rassekh
SR, Deyell RJ, Batist G, Karsan A, Wyatt AW, Johnson N, Scott DW
and Morin RD: Evaluating the quantity, quality and size
distribution of cell-free DNA by multiplex droplet digital PCR. Sci
Rep. 10(12564)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Stawski R, Stec-Martyna E, Chmielecki A,
Nowak D and Perdas E: Current Trends in Cell-Free DNA applications.
scoping review of clinical trials. Biology (Basel).
10(906)2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Has C, Bauer JW, Bodemer C, Bolling MC,
Bruckner-Tuderman L, Diem A, Fine JD, Heagerty A, Hovnanian A,
Marinkovich MP, et al: Consensus reclassification of inherited
epidermolysis bullosa and other disorders with skin fragility. Br J
Dermatol. 183:614–627. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Almaani N, Liu L, Harrison N, Tanaka A,
Lai-Cheong J, Mellerio JE and McGrath JA: New glycine substitution
mutations in type VII collagen underlying epidermolysis bullosa
pruriginosa but the phenotype is not explained by a common
polymorphism in the matrix metalloproteinase-1 gene promoter. Acta
Derm Venereol. 89:6–11. 2009.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yu Y, Wang Z, Mi Z, Sun L, Fu X, Yu G,
Pang Z, Liu H and Zhang F: Epidermolysis Bullosa in Chinese
Patients: Genetic analysis and mutation landscape in 57 pedigrees
and sporadic cases. Acta Derm Venereol.
101(adv00503)2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Brick K, Hand JL, Frankel AS, Siegel DH,
Thomas KB, El-Azhary R and Krol A: Epidermolysis bullosa
pruriginosa: Further clarification of the phenotype. Pediatr
Dermatol. 29:732–737. 2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Wagner RN, Piñón Hofbauer J, Wally V,
Kofler B, Schmuth M, De Rosa L, De Luca M and Bauer JW: Epigenetic
and metabolic regulation of epidermal homeostasis. Exp Dermatol.
30:1009–1022. 2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Rami A, Łaczmański Ł, Jacków-Nowicka J and
Jacków J: Reprogramming and differentiation of cutaneous squamous
cell carcinoma cells in recessive dystrophic epidermolysis Bullosa.
Int J Mol Sci. 22(245)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Taylor-Phillips S, Freeman K, Geppert J,
Agbebiyi A, Uthman OA, Madan J and Clarke A, Quenby S and Clarke A:
Accuracy of non-invasive prenatal testing using cell-free DNA for
detection of Down, Edwards and Patau syndromes: A systematic review
and meta-analysis. BMJ Open. 6(e010002)2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Hu P, Liang D, Chen Y, Lin Y, Qiao F, Li
H, Wang T, Peng C, Luo D, Liu H and Xu Z: An enrichment method to
increase cell-free fetal DNA fraction and significantly reduce
false negatives and test failures for non-invasive prenatal
screening: A feasibility study. J Transl Med.
17(124)2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Gerson KD, Truong S, Haviland MJ, O'Brien
BM, Hacker MR and Spiel MH: Low fetal fraction of cell-free DNA
predicts placental dysfunction and hypertensive disease in
pregnancy. Pregnancy Hypertens. 16:148–153. 2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Wang E, Batey A, Struble C, Musci T, Song
K and Oliphant A: Gestational age and maternal weight effects on
fetal cell-free DNA in maternal plasma. Prenat Diagn. 33:662–666.
2013.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Hou Y, Yang J, Qi Y, Guo F, Peng H, Wang
D, Wang Y, Luo X, Li Y and Yin A: Factors affecting cell-free DNA
fetal fraction: Statistical analysis of 13,661 maternal plasmas for
non-invasive prenatal screening. Hum Genomics.
13(62)2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Zhou Y, Wang Y, Addai FP, Li X, Zhang X,
Liu H, Yang G, Zeng F, Jiang T and Liu J: Analysis of cell-free
fetal DNA in 16,843 pregnant women from a single center in China
using targeted sequencing approach. Placenta. 122:18–22.
2022.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Khan FF, Khan N, Rehman S, Ejaz A, Ali U,
Erfan M, Ahmed ZM and Naeem M: Identification and computational
analysis of novel pathogenic variants in Pakistani families with
diverse epidermolysis bullosa phenotypes. Biomolecules.
11(620)2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Fatima Y, Shabbir MA, Makhdoom SI,
Saleem-ur-Rehman H, Waseem M, Jabeen K, Laila SU, Shahid A and
Naveed M: Pharmacophore based drug designing of COL7A1; The
causative gene of dystrophic epidermolysis Bullosa. BioScientific
Review. 3:11–26. 2021.
|
|
47
|
Klingberg S, Mortimore R, Parkes J, Chick
JE, Clague AE, Murrell D, Weedon D and Glass IA: Prenatal diagnosis
of dominant dystrophic epidermolysis bullosa, by COL7A1 molecular
analysis. Prenat Diagn. 20:618–622. 2000.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Wang Y, Song Z, Zhang L, Li N, Zhao J,
Yang R, Ji S and Sun P: Genetic analysis and prenatal diagnosis of
recessive dystrophic epidermolysis bullosa caused by compound
heterozygous variants of the COL7A1 gene in a Chinese family. Front
Pediatr. 10(941201)2022.PubMed/NCBI View Article : Google Scholar
|
